Akero Therapeutics, Inc.
Long

(AKRO) akero therapeutics daily chart review by projectsyndicate

287
long-term buy and hold from 18
target is +70% near 30.
get ready to buy dips later in q1 2020.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.